# OXCARBAZEPINE
> **ANDA220281** · Abbreviated New Drug Application (Generic) · Sponsor: STERANCO HLTHCARE · Approved 2026-03-09
## Drug
- **FDA Application Number:** ANDA220281
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** Oxcarbazepine
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** STERANCO HLTHCARE
- **First approval:** 2026-03-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220281)
---
*MORVS · CC0 1.0*